In this special collection we present a selection of recent papers published in Nature and Nature Reviews Cancer that highlight the burgeoning interest in cancer metabolism.
That cancers display an altered cellular metabolism was first recognized almost a century ago, notably in Otto Warburg's description of a switch in glucose metabolism from oxidative phosphorylation to glycolysis — the Warburg effect. However, as described in the Review by Tak W. Mak and colleagues, only recently have links been established between the oncogenic pathways that drive tumorigenesis and the mechanistic basis of tumour cell metabolism. A picture is now emerging showing that cancer-related genes, such as MYC (Liu, L. et al) and isocitrate dehydrogenase 1 (Sasaki, M. et al), have substantial effects on cancer cell metabolism.
The complexities surrounding cancer metabolism are nicely summed up in the News & Views article by Robert Svensson and Reuben Shaw, which discusses AMP kinase (AMPK). This kinase is a central sensor of cellular metabolism that can both promote and suppress cancer progression. The reasons why this and other proteins associated with cancer development and metabolism can show such different effects are unclear, but they might reflect our previous inability to study cellular metabolism in its entirety, relying instead on isolated snapshots of a complex and interconnected network. Approaches that address the wider aspects of cancer metabolism have enabled Claudio Scuoppo and colleagues to show that genes involved in the polyamine–hypusine axis suppress lymphoma development, and Richard Possemato and colleagues to show that certain breast cancers are dependent on serine because of overexpression of phosphoglycerate dehydrogenase.
Tumour metabolism is also influenced by systemic metabolic status. Bruce Spiegelman and colleagues discuss potential mechanisms through which obesity contributes to cancer development.
The Human Metabolome Database currently lists some 8,500 metabolites; but numbers are expected to rise and eventually to exceed the number of human genes. Despite this complexity, a better understanding of metabolic processes will hopefully pave the way to new therapeutic interventions.
All content for this Web collection has been chosen by the collection editors and certain papers have been made freely available for 6 months thanks to support from Teva Phamaceuticals.
Barbara Marte, Senior Editor, Nature
Nicola McCarthy, Chief Editor, Nature Reviews Cancer
Sarah Seton-Rogers, Senior Editor, Nature Reviews Cancer
Original Research papers
A tumour suppressor network relying on the polyamine–hypusine axis FREE
Claudio Scuoppo, Cornelius Miething, Lisa Lindqvist, José Reyes, Cristian Ruse, Iris Appelmann, Seungtai Yoon, Alexander Krasnitz, Julie Teruya-Feldstein, Darryl Pappin, Jerry Pelletier & Scott W. Lowe
doi:10.1038/nature11126
Nature 487, 244-248 (2012)
AMD1 and eIF5A are identified as two genes involved in the polyamine–hypusine pathway, a new tumour suppressor network regulating apoptosis.
IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigenetics FREE
Masato Sasaki, Christiane B. Knobbe, Joshua C. Munger, Evan F. Lind, Dirk Brenner, Anne Brüstle, Isaac S. Harris, Roxanne Holmes, Andrew Wakeham, Jillian Haight, Annick You-Ten, Wanda Y. Li, Stefanie Schalm, Shinsan M. Su, Carl Virtanen, Guido Reifenberger, Pamela S. Ohashi, Dwayne L. Barber, Maria E. Figueroa, Ari Melnick, Juan-Carlos Zúñiga-Pflücker & Tak W. Mak
doi:10.1038/nature11323
Nature 488, 656-659 (2012)
Mutations in isocitrate dehydrogenases IDH1 and IDH2 are common in human gliomas and acute myeloid leukaemias; here, mice that carry the IDH1(R132H) mutation are described, in a new model that should help in investigating the links between mutant IDH1 and leukaemia.
AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress
Sang-Min Jeon, Navdeep S. Chandel & Nissim Hay
doi:10.1038/nature11066
Nature 485, 661-665 (2012)
A mechanism is suggested that helps tumour cells survive energy stress conditions during early stages of tumorigenesis.
Deregulated MYC expression induces dependence upon AMPK-related kinase 5 FREE
Lidan Liu, Jannes Ulbrich, Judith Müller, Torsten Wüstefeld, Lukas Aeberhard, Theresia R. Kress, Nathiya Muthalagu, Lukas Rycak, Ramona Rudalska, Roland Moll, Stefan Kempa, Lars Zender, Martin Eilers & Daniel J. Murphy
doi:10.1038/nature10927
Nature, 483, 608-612 (2012)
Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation
Peppi Koivunen, Sungwoo Lee, Christopher G. Duncan, Giselle Lopez, Gang Lu, Shakti Ramkissoon, Julie A. Losman, Päivi Joensuu, Ulrich Bergmann, Stefan Gross, Jeremy Travins, Samuel Weiss, Ryan Looper, Keith L. Ligon, Roel G. W. Verhaak, Hai Yan & William G. Kaelin
doi:10.1038/nature10898
Nature, 483, 484-488 (2012)
IDH mutation impairs histone demethylation and results in a block to cell differentiation
Chao Lu, Patrick S. Ward, Gurpreet S. Kapoor, Dan Rohle, Sevin Turcan, Omar Abdel-Wahab, Christopher R. Edwards, Raya Khanin, Maria E. Figueroa, Ari Melnick, Kathryn E. Wellen, Donald M. O’Rourke, Shelley L. Berger, Timothy A. Chan, Ross L. Levine, Ingo K. Mellinghoff & Craig B. Thompson
doi:10.1038/nature10860
Nature, 483, 474�478 (2012)
IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
Sevin Turcan, Daniel Rohle, Anuj Goenka, Logan A. Walsh, Fang Fang, Emrullah Yilmaz, Carl Campos, Armida W. M. Fabius, Chao Lu, Patrick S. Ward, Craig B. Thompson, Andrew Kaufman, Olga Guryanova, Ross Levine, Adriana Heguy, Agnes Viale, Luc G. T. Morris, Jason T. Huse, Ingo K. Mellinghoff & Timothy A. Chan
doi:10.1038/nature10866
Nature, 483, 479�483 (2012)
Reductive carboxylation supports growth in tumour cells with defective mitochondria
Andrew R. Mullen, William W. Wheaton, Eunsook S. Jin, Pei-Hsuan Chen, Lucas B. Sullivan, Tzuling Cheng, Youfeng Yang, W. Marston Linehan, Navdeep S. Chandel & Ralph J. DeBerardinis
doi:10.1038/nature10642
Nature 481, 385-388 (2012)
Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia
Christian M. Metallo, Paulo A. Gameiro, Eric L. Bell, Katherine R. Mattaini, Juanjuan Yang, Karsten Hiller, Christopher M. Jewell, Zachary R. Johnson, Darrell J. Irvine, Leonard Guarente, Joanne K. Kelleher, Matthew G. Vander Heiden, Othon Iliopoulos & Gregory Stephanopoulos
doi:10.1038/nature10602
Nature 481, 380-384 (2012)
Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation
Weiwei Yang, Yan Xia, Haitao Ji, Yanhua Zheng, Ji Liang, Wenhua Huang, Xiang Gao, Kenneth Aldape & Zhimin Lu
doi:10.1038/nature10598
Nature 478, 118-122 (2011)
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor FREE
Christiane A. Opitz, Ulrike M. Litzenburger, Felix Sahm, Martina Ott, Isabel Tritschler, Saskia Trump, Theresa Schumacher, Leonie Jestaedt, Dieter Schrenk, Michael Weller, Manfred Jugold, Gilles J. Guillemin, Christine L. Miller, Christian Lutz, Bernhard Radlwimmer, Irina Lehmann, Andreas von Deimling, Wolfgang Wick & Michael Platten
doi:10.1038/nature10491
Nature 478, 197-203 (2011)
Human metabolic individuality in biomedical and pharmaceutical research
Karsten Suhre, So-Youn Shin, Ann-Kristin Petersen, Robert P. Mohney, David Meredith, Brigitte Wägele, Elisabeth Altmaier, CARDIoGRAM, Panos Deloukas, Jeanette Erdmann, Elin Grundberg, Christopher J. Hammond, Martin Hrabé de Angelis, Gabi Kastenmüller, Anna Köttgen, Florian Kronenberg, Massimo Mangino, Christa Meisinger, Thomas Meitinger, Hans-Werner Mewes, Michael V. Milburn, Cornelia Prehn, Johannes Raffler, Janina S. Ried, Werner Römisch-Margl, Nilesh J. Samani, Kerrin S. Small, H. -Erich Wichmann, Guangju Zhai, Thomas Illig, Tim D. Spector, Jerzy Adamski, Nicole Soranzo & Christian Gieger
doi:10.1038/nature10354
Nature 477, 54-60 (2011)
Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase
Christian Frezza, Liang Zheng, Ori Folger, Kartik N. Rajagopalan, Elaine D. MacKenzie, Livnat Jerby, Massimo Micaroni, Barbara Chaneton, Julie Adam, Ann Hedley, Gabriela Kalna, Ian P. M. Tomlinson, Patrick J. Pollard, Dave G. Watson, Ralph J. Deberardinis, Tomer Shlomi, Eytan Ruppin & Eyal Gottlieb
doi:10.1038/nature10363
Nature 477, 225-228 (2011)
Functional genomics reveal that the serine synthesis pathway is essential in breast cancer FREE
Richard Possemato, Kevin M. Marks, Yoav D. Shaul, Michael E. Pacold, Dohoon Kim, Kıvanç Birsoy, Shalini Sethumadhavan, Hin-Koon Woo, Hyun G. Jang, Abhishek K. Jha, Walter W. Chen, Francesca G. Barrett, Nicolas Stransky, Zhi-Yang Tsun, Glenn S. Cowley, Jordi Barretina, Nada Y. Kalaany, Peggy P. Hsu, Kathleen Ottina, Albert M. Chan, Bingbing Yuan, Levi A. Garraway, David E. Root, Mari Mino-Kenudson, Elena F. Brachtel, Edward M. Driggers & David M. Sabatini
doi:10.1038/nature10350
Nature 476, 346-350 (2011)
Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells
Andrea Facciabene, Xiaohui Peng, Ian S. Hagemann, Klara Balint, Andrea Barchetti, Li-Ping Wang, Phyllis A. Gimotty, C. Blake Gilks, Priti Lal, Lin Zhang & George Coukos
doi:10.1038/nature10169
Nature 475, 226-230 (2011)
Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
Gina M. DeNicola, Florian A. Karreth, Timothy J. Humpton, Aarthi Gopinathan, Cong Wei, Kristopher Frese, Dipti Mangal, Kenneth H. Yu, Charles J. Yeo, Eric S. Calhoun, Francesca Scrimieri, Jordan M. Winter, Ralph H. Hruban, Christine Iacobuzio-Donahue, Scott E. Kern, Ian A. Blair & David A. Tuveson
doi:10.1038/nature10189
Nature 475, 106-109 (2011)
Structure of mammalian AMPK and its regulation by ADP
Bing Xiao, Matthew J. Sanders, Elizabeth Underwood, Richard Heath, Faith V. Mayer, David Carmena, Chun Jing, Philip A. Walker, John F. Eccleston, Lesley F. Haire, Peter Saiu, Steven A. Howell, Rein Aasland, Stephen R. Martin, David Carling & Steven J. Gamblin
doi:10.1038/nature09932
Nature 472, 230-233 (2011)
Telomere dysfunction induces metabolic and mitochondrial compromise
Ergün Sahin, Simona Colla, Marc Liesa, Javid Moslehi, Florian L. Müller, Mira Guo, Marcus Cooper, Darrell Kotton, Attila J. Fabian, Carl Walkey, Richard S. Maser, Giovanni Tonon, Friedrich Foerster, Robert Xiong, Y. Alan Wang, Sachet A. Shukla, Mariela Jaskelioff, Eric S. Martin, Timothy P. Heffernan, Alexei Protopopov, Elena Ivanova, John E. Mahoney, Maria Kost-Alimova, Samuel R. Perry, Roderick Bronson, Ronglih Liao, Richard Mulligan, Orian S. Shirihai, Lynda Chin & Ronald A. DePinho
doi:10.1038/nature09787
Nature 470, 359-365 (2011)
Lkb1 regulates cell cycle and energy metabolism in haematopoietic stem cells
Daisuke Nakada, Thomas L. Saunders & Sean J. Morrison
doi:10.1038/nature09571
Nature 468, 653-658 (2010)
Lkb1 regulates quiescence and metabolic homeostasis of haematopoietic stem cells
Boyi Gan, Jian Hu, Shan Jiang, Yingchun Liu, Ergün Sahin, Li Zhuang, Eliot Fletcher-Sananikone, Simona Colla, Y. Alan Wang, Lynda Chin & Ronald A. DePinho
doi:10.1038/nature09595
Nature 468, 701-704 (2010)
The Lkb1 metabolic sensor maintains haematopoietic stem cell survival
Sushma Gurumurthy, Stephanie Z. Xie, Brinda Alagesan, Judith Kim, Rushdia Z. Yusuf, Borja Saez, Alexandros Tzatsos, Fatih Ozsolak, Patrice Milos, Francesco Ferrari, Peter J. Park, Orian S. Shirihai, David T. Scadden & Nabeel Bardeesy
doi:10.1038/nature09572
Nature 468, 659-663 (2010)
Heteroplasmic mitochondrial DNA mutations in normal and tumour cells
Yiping He, Jian Wu, Devin C. Dressman, Christine Iacobuzio-Donahue, Sanford D. Markowitz, Victor E. Velculescu, Luis A. Diaz Jr, Kenneth W. Kinzler, Bert Vogelstein & Nickolas Papadopoulos
doi:10.1038/nature08802
Nature 464, 610-614 (2010)
HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer
Charles J. David, Mo Chen, Marcela Assanah, Peter Canoll & James L. Manley
doi:10.1038/nature08697
Nature 463, 364-368 (2010)
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Lenny Dang, David W. White, Stefan Gross, Bryson D. Bennett, Mark A. Bittinger, Edward M. Driggers, Valeria R. Fantin, Hyun Gyung Jang, Shengfang Jin, Marie C. Keenan, Kevin M. Marks, Robert M. Prins, Patrick S. Ward, Katharine E. Yen, Linda M. Liau, Joshua D. Rabinowitz, Lewis C. Cantley, Craig B. Thompson, Matthew G. Vander Heiden & Shinsan M. Su
doi:10.1038/nature08617
Nature 462, 739-744 (2009)
Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment
Zachary T. Schafer, Alexandra R. Grassian, Loling Song, Zhenyang Jiang, Zachary Gerhart-Hines, Hanna Y. Irie, Sizhen Gao, Pere Puigserver & Joan S. Brugge
doi:10.1038/nature08268
Nature 462, 109-113 (2009)
Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression
Arun Sreekumar, Laila M. Poisson, Thekkelnaycke M. Rajendiran, Amjad P. Khan, Qi Cao, Jindan Yu, Bharathi Laxman, Rohit Mehra, Robert J. Lonigro, Yong Li, Mukesh K. Nyati, Aarif Ahsan, Shanker Kalyana-Sundaram, Bo Han, Xuhong Cao, Jaeman Byun, Gilbert S. Omenn, Debashis Ghosh, Subramaniam Pennathur, Danny C. Alexander, Alvin Berger, Jeffrey R. Shuster, John T. Wei, Sooryanarayana Varambally, Christopher Beecher & Arul M. Chinnaiyan
doi:10.1038/nature07762
Nature 457, 910-914 (2009)
Magnetic resonance imaging of pH in vivo using hyperpolarized 13C-labelled bicarbonate
Ferdia A. Gallagher, Mikko I. Kettunen, Sam E. Day, De-En Hu, Jan Henrik Ardenkjær-Larsen, René in ‘t Zandt, Pernille R. Jensen, Magnus Karlsson, Klaes Golman, Mathilde H. Lerche & Kevin M. Brindle
doi:10.1038/nature07017
Nature 453, 940-943 (2008)
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Heather R. Christofk, Matthew G. Vander Heiden, Marian H. Harris, Arvind Ramanathan, Robert E. Gerszten, Ru Wei, Mark D. Fleming, Stuart L. Schreiber & Lewis C. Cantley
doi:10.1038/nature06734
Nature 452, 230-233 (2008)
Pyruvate kinase M2 is a phosphotyrosine-binding protein
Heather R. Christofk, Matthew G. Vander Heiden, Ning Wu, John M. Asara & Lewis C. Cantley
doi:10.1038/nature06667
Nature 452, 181-186 (2008)
Reviews
Mitochondria and cancer
Douglas C. Wallace
doi:10.1038/nrc3365
Nature Reviews Cancer 12, 685-698 (2012)
What have mitochondria ever done for us? This Review discusses why alterations in cellular processes that require mitochondria are essential for tumorigenesis.
Article series: Epigenetics and genetics
The role of mutations in epigenetic regulators in myeloid malignancies
Alan H. Shih, Omar Abdel-Wahab, Jay P. Patel & Ross L. Levine
doi:10.1038/nrc3343
Nature Reviews Cancer 12, 599-612 (2012)
Alterations to epigenetic regulators are a recently characterized class of oncogenic changes in myeloid malignancies. This Review discusses what these alterations mean for leukaemogenesis.
Aiding and abetting roles of NOX oxidases in cellular transformation
Karen Block & Yves Gorin
doi:10.1038/nrc3339
Nature Reviews Cancer 12, 627-637 (2012)
NADPH oxidases of the NOX family are reactive oxygen species-generating enzymes that regulate redox-sensitive signalling pathways. In this Review, the authors discuss primary targets and redox-linked signalling systems that are influenced by NOX-derived ROS and the biological role that NOX oxidases might have in the aetiology of cancer.
The insulin and insulin-like growth factor receptor family in neoplasia: an update
Michael Pollak
doi:10.1038/nrc3215
Nature Reviews Cancer 12, 159-169 (2012)
This Review reflects on the recent disappointing initial results from Phase III trials of insulin-like growth factor I receptor (IGF1R)-specific antibodies for cancer treatment, and discusses the next steps in targeting insulin and IGFI signalling in cancer therapy.
The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention
Jeffrey M. Peters, Yatrik M. Shah & Frank J. Gonzalez
doi:10.1038/nrc3214
Nature Reviews Cancer 12, 181-195 (2012)
Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors that are involved in regulating glucose and lipid homeostasis, inflammation, proliferation and differentiation. This Review discusses the roles of PPARs in cancer and focuses on PPARβ/δ and the controversies yet to be resolved.
HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression
Brian Keith, Randall S. Johnson & M. Celeste Simon
doi:10.1038/nrc3183
Nature Reviews Cancer 12, 9-22 (2012)
The α-subunits that form the oxygen-sensitive component of the hypoxia-inducible factor (HIF) transcription factor have unique and overlapping roles in mediating cellular responses to hypoxia. Surprisingly, they can also have opposing roles, and the differences between HIF1α and HIF2α are discussed in this Review.
Choline metabolism in malignant transformation
Kristine Glunde, Zaver M. Bhujwalla & Sabrina M. Ronen
doi:10.1038/nrc3162
Nature Reviews Cancer 11, 835-848 (2011)
Choline metabolism is commonly deregulated in cancer, leading to increased levels of choline metabolites. This Review discusses the deregulation of choline metabolism in cancer, its reciprocal interaction with oncogenic signalling and the possible clinical applications in diagnostics and therapy.
Targeting hypoxia in cancer therapy
William R. Wilson & Michael P. Hay
doi:10.1038/nrc3064
Nature Reviews Cancer 11, 393-410 (2011)
Hypoxia is common in developing and advanced tumours and could therefore provide a means for drug selectivity. As discussed in this Review, this can be achieved either by using prodrugs that are activated in hypoxic regions, or by directly targeting hypoxia-induced signalling pathways that confer survival to tumour cells.
Otto Warburg's contributions to current concepts of cancer metabolism
Willem H. Koppenol, Patricia L. Bounds & Chi V. Dang
doi:10.1038/nrc3038
Nature Reviews Cancer 11, 325-337 (2011)
Otto Warburg has contributed important data and hypotheses to the fields of cancer research and metabolism, but what did he actually find and what conclusions did he draw? This Review looks at the life and research of Otto Warburg and places his work in the context of our current understanding of metabolism and hypoxia in cancer.
Regulation of cancer cell metabolism FREE
Rob A. Cairns, Isaac S. Harris & Tak W. Mak
doi:10.1038/nrc2981
Nature Reviews Cancer 11, 85-95 (2011)
Fundamental differences in the regulation of central metabolic pathways exist between tumours and normal tissue. This Review discusses how the Warburg effect is still applicable to our view of cancer metabolism and new advances in understanding beyond this hypothesis, including regulating anapleurosis and the redox balance.
Activity-based protein profiling for biochemical pathway discovery in cancer
Daniel K. Nomura, Melissa M. Dix & Benjamin F. Cravatt
doi:10.1038/nrc2901
Nature Reviews Cancer 10, 630-638 (2010)
This Review focuses on activity-based protein profiling, which enables the discovery of cancer-relevant enzymes and selective pharmacological probes to perturb and characterize these proteins in tumour cells. When ABPP is integrated with other large-scale profiling methods, it can provide insight into the metabolic and signalling pathways that support cancer pathogenesis and indicate new strategies for treatment.
Targeting metabolic transformation for cancer therapy
Daniel A. Tennant, Raúl V. Durán & Eyal Gottlieb
doi:10.1038/nrc2817
Nature Reviews Cancer 10, 267-277 (2010)
This Review discusses the progress made with developing drugs that specifically target the altered metabolic pathways of tumours and suggests additional targets that might also be beneficial.
Linking functional decline of telomeres, mitochondria and stem cells during ageing
Ergün Sahin & Ronald A. DePinho
doi:10.1038/nature08982
Nature 464, 520-528 (2010)
Perspective
NRF2 and cancer: the good, the bad and the importance of context
Michael B. Sporn & Karen T. Liby
doi:10.1038/nrc3278
Nature Reviews Cancer 12, 564-571 (2012)
NFE2-related factor 2 (NRF2) has apparently contradictory roles in cancer. Activation of NRF2 contributes to the chemopreventive effects of various clinically used drugs against various diseases including cancer. However, NRF2 activity can also accelerate tumorigenesis in mouse models, thus highlighting a potential danger of NRF2 activation. This Opinion article discusses how these opposing roles might be reconciled.
Molecular mechanisms of cancer development in obesity FREE
Melin J. Khandekar, Paul Cohen & Bruce M. Spiegelman
doi:10.1038/nrc3174
Nature Reviews Cancer 11, 886-895 (2011)
Obesity is increasing in the developed world, and epidemiological studies indicate that this is accompanied by an increased risk of cancer. This Opinion article discusses the possible mechanisms by which obesity might promote tumorigenesis.
News and Views
Cancer metabolism: Tumour friend or foe FREE
Robert U. Svensson & Reuben J. Shaw
doi:10.1038/485590a
Nature 485, 590-591 (2012)
Cancer: Sacrifice for survival
Nana-Maria Grüning & Markus Ralser
doi:10.1038/480190a
Nature 480, 190-191 (2011)
Cancer: Why tumours eat tryptophan
George C. Prendergast
doi:10.1038/478192a
Nature 478, 192-194 (2011)
Cancer: When antioxidants are bad
Rushika M. Perera & Nabeel Bardeesy
doi:10.1038/475043a
Nature 475, 43-44 (2011)
Genomics: Drugs, diabetes and cancer
Morris J. Birnbaum & Reuben J. Shaw
doi:10.1038/470338a
Nature 470, 338-339 (2011)
Q&A: Cancer: Clues from cell metabolism
William G. Kaelin, Jr & Craig B. Thompson
doi:10.1038/465562a
Nature 465, 562-564 (2010)
Research Highlights
Tumour suppressors: At the hypusine of the crime
Darren J. Burgess
doi:10.1038/nrc3325
Nature Reviews Cancer 12, 509 (2012)
An in vivo short hairpin RNA screen identifies tumour suppressor genes in commonly deleted regions in lymphoma.
Metabolism: Unravelling metabolic dependencies
Darren J. Burgess
doi:10.1038/nrc3273
Nature Reviews Cancer 12, 321 (2012)
A new study identifies a metabolic dependency in prostate cancer cells.
Metabolism: Unmasking an oncometabolite
Nicola McCarthy
doi:10.1038/nrc3248
Nature Reviews Cancer 12, 229 (2012)
Mutant IDH genes that produce 2-hydroxyglutarate can influence cell transformation through effects on DNA and histone methylation and hypoxia inducible factors.
Cancer: Blocking tumour sugar metabolism
doi:10.1038/483512b
Nature 12, 512 (2012)
Genetics: IDH mosaicism in enchondromatosis syndromes
Gemma K. Alderton
doi:10.1038/nrc3194
Nature Reviews Cancer 12, 6-7 (2012)
Two papers in Nature Genetics show that the isocitrate dehydrogenases IDH1 and IDH2 are mutated in two subtypes of the cancer-prone enchondromatosis syndrome.
Kidney tumours: 'NRF said
Nicola McCarthy
doi:10.1038/nrc3175
Nature Reviews Cancer 11, 833 (2011)
Two papers have identified a new pathway through which the loss of the tumour suppressor fumarate hydratase might promote tumour development.
Metabolism: Letting glucose take hold
Gemma K. Alderton
doi:10.1038/nrc3159
Nature Reviews Cancer 11, 756 (2011)
Daley and colleagues show that LIN28-mediated suppression of let-7 microRNAs activates the insulin–PI3K–mTOR pathway to regulate glucose metabolism, connecting type 2 diabetes and cancer.
Metabolism: Catabolic effects
Sarah Seton-Rogers
doi:10.1038/nrc3161
Nature Reviews Cancer 11, 757 (2011)
A recent Nature paper identifies a catabolite of tryptophan as an endogenous ligand of aryl hydrocarbon receptor and links this pathway to tumorigenesis and suppression of antitumour immunity.
Metabolism: Haem is where the heart is
Nicola McCarthy
doi:10.1038/nrc3145
Nature Reviews Cancer 11, 692-693 (2011)
This Nature paper shows that inhibition of haem oxygenase 1 is synthetic lethal in kidney cells lacking the tumour suppressor fumarate hydratase.
Metabolism: Flexible flux
Sarah Seton-Rogers
doi:10.1038/nrc3128
Nature Reviews Cancer 11, 621 (2011)
Using unbiased functional genomics and metabolomics methods, two groups have demonstrated the importance of the serine synthesis pathway for tumorigenesis.
Systems biology: Lethal weaknesses
Nicola McCarthy
doi:10.1038/nrc3109
Nature Reviews Cancer 11, 538-539 (2011)
A new genomic-scale computer model of the cancer metabolome indicates synthetic lethal interactions.
Cancer metabolism: Feed it forward
Sarah Seton-Rogers
doi:10.1038/nrc3094
Nature Reviews Cancer 11, 461 (2011)
Semenza and colleagues identify a positive feedback loop between the pyruvate kinase PKM2 and HIF1 that may explain how PKM2 can promote metabolic reprogramming of cancer cells.
Hypoxia: HIF switch
Sarah Seton-Rogers
doi:10.1038/nrc3074
Nature Reviews Cancer 11, 391 (2011)
The switch from HIF1α-dependent to HIF2α-dependent responses may be partly mediated through the ubiquitin ligase HAF, leading to increased tumour initiation and progression.
Metabolism: The mitochondria that wag the dog
Teresa Villanueva
doi:10.1038/nrc3026
Nature Reviews Cancer 11, 155 (2011)
Canine tumours steal mitochondria from their hosts.
Metabolism: Choose your carbon source
Darren J. Burgess
doi:10.1038/nrc3009
Nature Reviews Cancer 11, 80-81 (2011)
A new study identifies a regulatory mechanism controlling carbon source uptake.